retatrutide triple agonist weight loss trial Agonism Based Therapies for Obesity Retatrutide: UK Availability, Price, Side

GLP-1 Drugs May Have Risk of Hair Loss As alopecia has been more frequently reported as a possible side effect of GLP-1 drugs, no large-scale, population-based studies have systematically captured hair loss as such

Listed Products of GLP-1 Receptor Agonists (GLP-1RA) At present, 9 GLP-1 receptor agonist hypoglycemic drugs have been approved for marketing in the world, namely: exenatide, liraglutide, Exenatide extended-release (exenatide ER), albiglutide, dulaglutide , lixisenatide, benaglutide, semaglutide, polyethylene glycol loxenatide injection and oral semaglutide

Micro-CT results showed that the RA group had severe destruction of articular cartilage and obvious osteophyte formation compared with the NC group

As appetite-suppressing injections spread, retailers are seeing lower food volumes but stronger demand for fresh, high-protein, and nutrient-dense options

Fast times

Status: SubmittedDenverDA approval in late 2025